MGTX (MGTX) affiliate files to sell 56,000 ordinary shares via Form 144

Rhea-AI Filing Summary

An affiliate of MGTX has filed to potentially sell up to 56,000 ordinary shares through Merrill Lynch on the NASDAQ market, with an aggregate market value of $700,560, based on a share balance of 92,609,516 ordinary shares outstanding. The shares proposed for sale arise from Incentive Compensation Stock Grants dated September 7, 2018 (1,569 shares) and December 7, 2018 (54,431 shares), and are listed for a proposed sale date of July 21, 2026.

Key Figures

Shares to be sold: 56,000 ordinary shares Aggregate market value: $700,560 Shares outstanding: 92,609,516 ordinary shares +3 more

6 metrics

Shares to be sold 56,000 ordinary shares Proposed sale under Form 144

Aggregate market value $700,560 Value of 56,000 ordinary shares proposed for sale

Shares outstanding 92,609,516 ordinary shares Ordinary shares outstanding cited in the Form 144

Grant from 09/07/2018 1,569 ordinary shares Incentive Compensation Stock Grant from issuer

Grant from 12/07/2018 54,431 ordinary shares Incentive Compensation Stock Grant from issuer

Proposed sale date 07/21/2026 Date for proposed sale of 56,000 ordinary shares

Key Terms

Form 144, Ordinary Shares, aggregate market value, Incentive Compensation Stock Grant

4 terms

Form 144 regulatory

"Form 144: Filer Information and securities to be sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Ordinary Shares financial

"144: Securities Information Ordinary Shares | Merrill Lynch"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

aggregate market value financial

"| 56000 | 700560 | 92609516 | 07/21/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Incentive Compensation Stock Grant financial

"Ordinary Shares | 09/07/2018 | Incentive Compensation Stock Grant"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/21/2026 - 09:09 PM Accepted by SEC EDGAR 07/21/2026 - 09:09 PM Learn about SEC filing dates

FAQ

What does the Form 144 filing by MGTX indicate?

The Form 144 indicates an affiliate of MGTX may sell up to 56,000 ordinary shares through Merrill Lynch on NASDAQ. The filing reflects an aggregate market value of $700,560 for these proposed sales.

How many MGTX shares are covered by this Form 144?

The filing covers a proposed sale of 56,000 ordinary shares of MGTX. These shares are linked to Incentive Compensation Stock Grants originally granted in 2018 and are listed for potential sale on NASDAQ.

What is the aggregate market value of the MGTX shares to be sold?

The aggregate market value of the 56,000 ordinary shares covered by this Form 144 is $700,560. This value is used for disclosure purposes in connection with the proposed sale via Merrill Lynch on NASDAQ.

How many MGTX shares are outstanding according to the Form 144?

According to the filing, there are 92,609,516 ordinary shares outstanding. This figure provides context for the 56,000 shares proposed to be sold under the Form 144 notice.

What is the source of the MGTX shares proposed for sale?

The proposed 56,000 ordinary shares come from Incentive Compensation Stock Grants dated September 7, 2018 (1,569 shares) and December 7, 2018 (54,431 shares). The issuer is listed as the grantor of these awards.

When is the proposed sale date for the MGTX shares in this Form 144?

The proposed sale date for the 56,000 ordinary shares is July 21, 2026. The shares are expected to be sold through Merrill Lynch on the NASDAQ market, subject to applicable rules.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Merrill Lynch One Bryant Park, 46th Floor New York NY 10036	56000	700560	92609516	07/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	09/07/2018	Incentive Compensation Stock Grant	Issuer			1569	09/07/2018	N/A
Ordinary Shares	12/07/2018	Incentive Compensation Stock Grant	Issuer			54431	12/07/2018	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)